Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer.

about

Chemoradiation-induced hearing loss remains a major concern for head and neck cancer patients.Utility of chemoradioselection for the optimization of treatment intensity in advanced hypopharyngeal and laryngeal carcinoma.

P2860

Q39448144-654E26C8-68E6-462E-A790-0AD4F023FD52 Q47391762-CA74F97B-0EDC-4B8A-879E-97E7B031B889

P2860

Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer.

Item

http://www.wikidata.org/entity/Q37436229

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Weekly versus every-three-week ...... mens for head and neck cancer.

@en

Weekly versus every-three-week ...... mens for head and neck cancer.

@nl

type

Item

label

Weekly versus every-three-week ...... mens for head and neck cancer.

@en

Weekly versus every-three-week ...... mens for head and neck cancer.

@nl

prefLabel

Weekly versus every-three-week ...... mens for head and neck cancer.

@en

Weekly versus every-three-week ...... mens for head and neck cancer.

@nl

P1476

Weekly versus every-three-week ...... imens for head and neck cancer

@en

P2093

James M Melotek

http://www.w3.org/2001/XMLSchema#string

Michael T Spiotto

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

Comparison of weekly administration of cisplatin versus three courses of cisplatin 100 mg/m(2) for definitive radiochemotherapy of locally advanced head-and-neck cancers.

Racial parities in outcomes after radiotherapy for head and neck cancer.

The comparison between weekly and three-weekly cisplatin delivered concurrently with radiotherapy for patients with postoperative high-risk squamous cell carcinoma of the oral cavity.

Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.

Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.

Acute kidney injury, mortality, length of stay, and costs in hospitalized patients.

P2888

s40463-016-0175-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40463-016-0175-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew Koshy

Joshua Silverman

Benjamin T Cooper

P577

2016-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1013499000

http://www.w3.org/2001/XMLSchema#string

P698

27881143

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

5121964

http://www.w3.org/2001/XMLSchema#string

Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer.

about

P2860

P2860

Weekly versus every-three-weeks platinum-based chemoradiation regimens for head and neck cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932